Loading...
Chemical structure of BRD0705

GC39181

BRD0705

Also known as (4S)-4-ethyl-7,7-dimethyl-4-phenyl-1,6,8,9-tetrahydropyrazolo[5,4-b]quinolin-5-one

BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor with an IC50 of 66 nM and a Kd of 4·8 μM· BRD0705 displays increased selectivity for GSK3α (8-fold) versus GSK3β (IC50 of 515 nM)· BRD0705 can be used for acute myeloid leukemia (AML) research

ChemicalCAS2056261-41-5MW321.42FormulaC20H23N3O
CAS number
2056261-41-5
Molecular weight
321.42
Formula
C20H23N3O
Solubility
DMSO： 300 mg/mL (933·36 mM)
InChIKey
NCKLQXXBRWCYMA-FQEVSTJZSA-N
Catalogue number
GC39181
Brand
GLPBIO
Computed properties PubChem CID 136980453 · XLogP 4.2 · TPSA 57.8 Ų · H-bond donors 2
XLogP
4.2
TPSA
57.8 Ų
H-bond donors
2
H-bond acceptors
3
Rotatable bonds
2
Heavy atoms
24

SMILES CC[C@@]1(C2=C(NC3=C1C(=O)CC(C3)(C)C)NN=C2)C4=CC=CC=C4

Computed descriptors from PubChem (CID 136980453), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.